Indicators for safe withdrawal of nucleos(t)ide analogues antivirals for chronic hepatitis BLIU Lu-jie, LIU Yan, LIU Xin-guang, XU Dong-ping203-208
Establishment of reference material of multiplex nucleic acid assay for bacterial infectionLIU Dong-lai, ZHOU Hai-wei, SHI Da-wei, SHEN Shu, TIAN Ya-bin, ZHANG Chun-tao209-214
Analysis for clinical detection and phenotypic features of HBV mutants resistant to both lamivudine and adefovirCHEN Rong-juan, LIU Yan, LI Xiao-dong, DU Feng-xia, SI Lan-lan, LI Le, XU Zhi-hui, YAO Zeng-tao, DAI Jiu-zeng, XU Dong-ping, DUAN Chang-zhu215-219
Meta analysis on efficacy and safety of transcatheter arterial chemoembolization combined with S-1 for primary hepatic carcinomaSUI Jing, MAN Mu-ran, ZHOU Xu-lin, GONG Ping, LIU Qing-hua220-226
Celastrol reduces triglyceride level in HepG2 cells by regulating lipid synthesis and oxidationFENG Ze-min, WAN Xing-yong, YU Chao-hui, LI You-ming227-230
Present situation and advance in cholangiocarcinoma locoregional therapyCHENG Jia-min, LIU Ze, DONG Zheng, DONG Jing-hui, LI Yin-yin, ZENG Zhen, YANG Xin-rui, LU Yin-ying245-247,254